2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Brandt Leonard J. | — | 9,838,777 | Aug 28, 2009 |
| McAdoo Capital, Inc. | — | 7,600,000 | Mar 12, 2012 |
| Zanett Opportunity Fund, Ltd. | — | 7,600,000 | Mar 12, 2012 |
| Niihara Yutaka | CEO | 7,500,000 | Jan 17, 2023 |
| Schindler Walter | — | 6,069,376 | Jul 14, 2014 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2024 | Kuwahara Jon | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 16, 2024 | Sep 18, 2024 | Lim Seah H. | Director | Buy | 60.0 | +20,000 | 0.44% | ✗ | $800 |
| Feb 26, 2024 | Feb 29, 2024 | LEE WILLIS C | COO | Buy | 91.3 | +115,200 | 16.93% | ✗ | $14.7K |
| Feb 1, 2024 | Feb 5, 2024 | Zwicker Ian Harvey | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | ZEN Wei Peu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Lim Seah H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Stark Charles William | CSO & EVP Clinical Development | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | Sekulich George | President | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | NAGASAKI YASUSHI | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 1, 2024 | Feb 5, 2024 | LEE WILLIS C | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 25, 2023 | Jan 3, 2024 | LEE WILLIS C | COO | Buy | 91.3 | +121,000 | 21.63% | ✗ | $15.3K |
| Dec 20, 2023 | Dec 21, 2023 | Lim Seah H. | Director | Sell | 37.5 | -32,500 | -0.70% | ✗ | $1.6K |
| Dec 20, 2023 | Lim Seah H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 9, 2022 | Dec 19, 2023 | Lim Seah H. | Director | Buy | 100.0 | +4,580,626 | 11897.73% | ✗ | $1.3M |
| Dec 15, 2023 | Dec 19, 2023 | ZEN Wei Peu | Director | Buy | 100.0 | +3,760,983 | 165.10% | ✗ | $1.1M |
| Aug 25, 2023 | Dec 4, 2023 | LEE WILLIS C | COO | Buy | 77.5 | +15,609 | 1.13% | ✗ | $2K |
| Sep 20, 2022 | Jun 2, 2023 | LEE WILLIS C | COO | Buy | 85.0 | +29,450 | 5.56% | ✗ | $8.5K |
| Jan 18, 2023 | Jan 20, 2023 | ZEN Wei Peu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 19, 2023 | LEE WILLIS C | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | Zwicker Ian Harvey | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | ZEN Wei Peu | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | Lim Seah H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | Stark Charles William | SVP, Clinical Development | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | Sekulich George | CIO & SVP | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | NAGASAKI YASUSHI | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | LEE WILLIS C | COO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jan 12, 2023 | Jan 17, 2023 | Niihara Yutaka | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 3, 2022 | Dec 1, 2022 | Niihara Yutaka | CEO | Buy | 61.3 | +52,600 | 0.43% | ✗ | $21.2K |
| Oct 31, 2022 | Nov 3, 2022 | Niihara Yutaka | CEO | Buy | 61.3 | +27,500 | 0.23% | ✗ | $12K |
| Oct 24, 2022 | Oct 31, 2022 | Niihara Yutaka | CEO | Buy | 68.8 | +69,400 | 0.58% | ✗ | $19.3K |
| Oct 19, 2022 | Oct 24, 2022 | Niihara Yutaka | CEO | Buy | 68.8 | +65,000 | 0.54% | ✗ | $11.3K |
| Oct 17, 2022 | Oct 19, 2022 | Niihara Yutaka | CEO | Buy | 60.0 | +45,000 | 0.38% | ✗ | $8.7K |
| Oct 13, 2022 | Oct 17, 2022 | Niihara Yutaka | CEO | Buy | 68.8 | +97,500 | 0.82% | ✗ | $17.2K |
| Oct 11, 2022 | Oct 13, 2022 | Niihara Yutaka | CEO | Buy | 78.8 | +165,000 | 1.41% | ✗ | $13.3K |
| Sep 26, 2022 | Oct 12, 2022 | Niihara Yutaka | CEO | Buy | 78.8 | +185,000 | 1.61% | ✗ | $20.4K |
| Oct 6, 2022 | Zwicker Ian Harvey | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 6, 2022 | Lim Seah H. | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 19, 2022 | Jul 25, 2022 | LEE WILLIS C | COO | Buy | 67.5 | +3,200 | 0.61% | ✗ | $1.2K |
| May 27, 2022 | Jun 3, 2022 | LEE WILLIS C | COO | Buy | 67.5 | +5,000 | 0.96% | ✗ | $1.9K |
| May 20, 2022 | Jun 2, 2022 | Niihara Yutaka | CEO | Buy | 55.0 | +7,000 | 0.06% | ✗ | $3.5K |
| May 9, 2022 | May 19, 2022 | Niihara Yutaka | CEO | Buy | 60.0 | +23,351 | 0.20% | ✗ | $9.6K |
| Apr 4, 2022 | Apr 12, 2022 | LEE WILLIS C | COO | Buy | 83.8 | +15,100 | 2.98% | ✗ | $13.5K |
| Feb 28, 2022 | Mar 2, 2022 | Niihara Yutaka | CEO | Buy | 65.0 | +53,800 | 0.47% | ✗ | $80.2K |
| Feb 22, 2022 | Feb 28, 2022 | LEE WILLIS C | COO | Buy | 83.8 | +21,100 | 4.34% | ✗ | $31.5K |
| Feb 24, 2022 | Feb 28, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +16,500 | 0.14% | ✗ | $23.5K |
| Feb 18, 2022 | Feb 23, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +19,300 | 0.17% | ✗ | $27.8K |
| Feb 16, 2022 | Feb 18, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +7,500 | 0.07% | ✗ | $10.8K |
| Feb 14, 2022 | Feb 16, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +12,000 | 0.11% | ✗ | $17.4K |
| Feb 9, 2022 | Feb 11, 2022 | Niihara Yutaka | CEO | Buy | 61.3 | +30,500 | 0.27% | ✗ | $44.4K |
| Feb 7, 2022 | Feb 9, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +8,500 | 0.08% | ✗ | $12.6K |
| Feb 3, 2022 | Feb 7, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +13,250 | 0.12% | ✗ | $18.8K |
| Jan 24, 2022 | Teranishi Lori | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jan 3, 2022 | Jan 5, 2022 | Lui Alfred Fu Kong | Director | Buy | 91.3 | +10,000 | 30.90% | ✗ | $15.8K |
| Dec 3, 2021 | Jan 5, 2022 | LEE WILLIS C | COO | Buy | 60.0 | +1,700 | 0.35% | ✗ | $2.6K |
| Dec 28, 2021 | Jan 3, 2022 | Niihara Yutaka | CEO | Buy | 56.3 | +17,500 | 0.16% | ✗ | $27.5K |
| Dec 28, 2021 | Stark Charles William | SVP, Clinical Development | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 22, 2021 | Dec 28, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +7,700 | 0.07% | ✗ | $11.4K |
| Dec 17, 2021 | Dec 22, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +10,650 | 0.09% | ✗ | $15.9K |
| Dec 20, 2021 | Sekulich George | CIO & SVP | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Dec 10, 2021 | Dec 17, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +9,500 | 0.08% | ✗ | $14.6K |
| Dec 6, 2021 | Dec 10, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +6,600 | 0.06% | ✗ | $10.5K |
| Dec 2, 2021 | Dec 6, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +4,400 | 0.04% | ✗ | $6.8K |
| Nov 30, 2021 | Dec 2, 2021 | Niihara Yutaka | CEO | Buy | 65.0 | +41,350 | 0.37% | ✗ | $63.6K |
| Nov 30, 2021 | Lui Alfred Fu Kong | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 26, 2021 | Nov 30, 2021 | LEE WILLIS C | COO | Buy | 95.0 | +55,533 | 12.96% | ✗ | $81.6K |
| Nov 26, 2021 | Nov 30, 2021 | Niihara Yutaka | CEO | Buy | 72.5 | +72,009 | 0.65% | ✗ | $102.2K |
| Nov 23, 2021 | Nov 26, 2021 | Niihara Yutaka | CEO | Buy | 61.3 | +26,300 | 0.24% | ✗ | $35.3K |
| Nov 23, 2021 | Nov 26, 2021 | LEE WILLIS C | COO | Buy | 90.0 | +38,000 | 9.73% | ✗ | $50.9K |
| Nov 15, 2021 | Nov 23, 2021 | LEE WILLIS C | COO | Buy | 86.3 | +18,600 | 5.00% | ✗ | $25.6K |
| Nov 19, 2021 | Nov 23, 2021 | Niihara Yutaka | CEO | Buy | 61.3 | +27,000 | 0.24% | ✗ | $38.1K |
| Nov 15, 2021 | Nov 19, 2021 | Niihara Yutaka | CEO | Buy | 61.3 | +33,000 | 0.30% | ✗ | $42.3K |
| Oct 20, 2021 | Oct 22, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +1,000 | 0.01% | ✗ | $1.6K |
| Oct 5, 2021 | Oct 7, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,000 | 0.03% | ✗ | $4.8K |
| Sep 27, 2021 | Sep 29, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +1,000 | 0.01% | ✗ | $1.6K |
| Sep 23, 2021 | Sep 27, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +2,500 | 0.02% | ✗ | $4.2K |
| Sep 21, 2021 | Sep 23, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,582 | 0.03% | ✗ | $6K |
| Sep 15, 2021 | Sep 17, 2021 | LEE WILLIS C | COO | Buy | 67.5 | +3,500 | 0.95% | ✗ | $5.6K |
| Sep 15, 2021 | Sep 17, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +2,000 | 0.02% | ✗ | $3K |
| Sep 9, 2021 | Sep 13, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +2,500 | 0.02% | ✗ | $4.2K |
| Sep 8, 2021 | Sep 10, 2021 | LEE WILLIS C | COO | Buy | 77.5 | +4,000 | 1.10% | ✗ | $6.8K |
| Sep 3, 2021 | Sep 8, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,000 | 0.03% | ✗ | $5K |
| Aug 31, 2021 | Sep 2, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +9,701 | 0.09% | ✗ | $15K |
| Aug 25, 2021 | Aug 27, 2021 | LEE WILLIS C | COO | Buy | 77.5 | +4,900 | 1.36% | ✗ | $7.6K |
| Aug 24, 2021 | Aug 26, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +13,200 | 0.12% | ✗ | $20.3K |
| Aug 19, 2021 | Aug 23, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +9,200 | 0.08% | ✗ | $13.3K |
| Aug 16, 2021 | Aug 18, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +4,700 | 0.04% | ✗ | $7K |
| Aug 11, 2021 | Aug 13, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +7,593 | 0.07% | ✗ | $11.6K |
| Aug 6, 2021 | Aug 10, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +5,100 | 0.05% | ✗ | $7.8K |
| Aug 3, 2021 | Aug 5, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +7,600 | 0.07% | ✗ | $11.2K |
| Jul 29, 2021 | Aug 2, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +4,100 | 0.04% | ✗ | $6.1K |
| Jul 26, 2021 | Jul 28, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,400 | 0.03% | ✗ | $5K |
| Jul 21, 2021 | Jul 23, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +5,200 | 0.05% | ✗ | $7.7K |
| Jul 16, 2021 | Jul 20, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +4,900 | 0.04% | ✗ | $7.2K |
| Jul 13, 2021 | Jul 15, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +5,300 | 0.05% | ✗ | $8K |
| Jul 8, 2021 | Jul 12, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +4,000 | 0.04% | ✗ | $6.2K |
| Jul 2, 2021 | Jul 7, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,900 | 0.04% | ✗ | $6K |
| Jun 29, 2021 | Jul 1, 2021 | Niihara Yutaka | CEO | Buy | 56.3 | +10,000 | 0.09% | ✗ | $14.5K |
| Jun 24, 2021 | Jun 28, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +3,800 | 0.03% | ✗ | $5.6K |
| Jun 18, 2021 | Jun 22, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +2,250 | 0.02% | ✗ | $3.6K |
| Jun 15, 2021 | Jun 17, 2021 | Niihara Yutaka | CEO | Buy | 47.5 | +2,490 | 0.02% | ✗ | $4K |